A STUDY TO COMPARE THE BLOOD LEVELS OF VITAMIN D AND INTERLEUKIN 17(AN INFLAMMATORY MARKER)IN VITILIGO PATIENTS AND NORMAL HEALTHY INDIVIDUALS
Not Applicable
Completed
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2020/09/027620
- Lead Sponsor
- DR ANJU GEORGE C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 84
Inclusion Criteria
Adult ( >18 years of age) patients of nonsegmental vitiligo seen in department of Dermatology, All India Institute of Medical Sciences, Raipur
Exclusion Criteria
1. Patients who had received systemic therapy for vitiligo in past 2 months
2. Those who have taken vitamin D supplements in last one year
3. Patients who had received phototherapy in last 3 months
4. Patients with other autoimmune diseases
5. Patients with chronic inflammatory diseases
6. Patients with severe anemia
7. Pregnant women and lactating mothers.
8. Patients who are not willing to participate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of interleukin 17 and 25- hydroxy vitamin D in nonsegmental vitiligo patients and healthy controlsTimepoint: FIRST POINT OF VISIT
- Secondary Outcome Measures
Name Time Method RELATION OF SERUM LEVELS OF INTERLEUKIN 17 AND 25 HYDROXY VITAMIN D WITH VITILIGO EXTENT AND ACTIVITYTimepoint: DURING ANALYSIS